semaglutide subcutaneous Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating 7.2 mg for obesity Wegovy® Pen Guide and Dosing

Supplier of assay kits, antibodies, biochemicals, and proteins and provider of contract research services

Practitioners should utilize the following checklist during the initial assessment for any patient currently prescribed an incretin-based therapy: Medication Phase : Identify if the patient is in the initiation, escalation, or maintenance phase of treatment

Neurological effects may play a role

The medication has Food and Drug Administration (FDA) approval for helping with long-term weight management and treating type 2 diabetes

Other recognised side effects include injection site reactions, fatigue, dizziness, headache, and increased resting heart rate (common)

The most common side effects of the drugs are nausea, diarrhoea, constipation and dehydration, although the US Food and Drug Administration last week revealed it was evaluating the risk of more serious side effects including hair loss and suicidal ideation